Customs duty waive off on Remdesivir will further augment domestic availability: Sadanand Gowda

"Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has reduced customs duty on #Remdesivir and its API/KSM. This step will further augment domestic availability of Remdesivir injection," Gowda said in a tweet.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vkLean
via IFTTT